CIK 0000874015
- Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 330336973
- Phone
- +1 760-931-9200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $148,200
- in 1 filing
- Open-market sales, last 90 days
- $61,389
- in 2 filings
Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-31 | BENNETT C FRANK EVP, Chief Scientific Officer | Other acquisition | +110 | $51.31 | $6K | 60,128 |
| 2026-07-07 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale 10b5-1 | −5,536 | $83.58 | $463K | 75,018 |
| 2026-07-07 | BENNETT C FRANK EVP, Chief Scientific Officer | Other acquisition 10b5-1 | +15,000 | 15,000 | ||
| 2026-07-07 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale 10b5-1 | −15,000 | $85.46 | $1.3M | 0 |
| 2026-07-07 | BENNETT C FRANK EVP, Chief Scientific Officer | Other disposition · Restricted Stock Unit 10b5-1 | −15,000 | 12,109 | ||
| 2026-03-03 | BENNETT C FRANK EVP, Chief Scientific Officer | Option exercise 10b5-1 | +16,463 | $32.60 | $537K | 117,017 |
| 2026-03-03 | BENNETT C FRANK EVP, Chief Scientific Officer | Option exercise 10b5-1 | +48,626 | $60.89 | $3.0M | 165,643 |
| 2026-03-03 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale 10b5-1 | −71,600 | $79.10 | $5.7M | 94,043 |
| 2026-03-03 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale 10b5-1 | −12,687 | $79.88 | $1.0M | 81,356 |
| 2026-03-03 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale 10b5-1 | −802 | $80.76 | $65K | 80,554 |
| 2026-03-03 | BENNETT C FRANK EVP, Chief Scientific Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −16,463 | 2,406 | ||
| 2026-03-03 | BENNETT C FRANK EVP, Chief Scientific Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −48,626 | 0 | ||
| 2026-02-27 | BENNETT C FRANK EVP, Chief Scientific Officer | Other acquisition | +261 | $48.87 | $13K | 100,554 |
| 2026-02-02 | BENNETT C FRANK EVP, Chief Scientific Officer | Other disposition | −0 | 100,293 | ||
| 2026-02-02 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale 10b5-1 | −20,000 | $82.60 | $1.7M | 80,293 |
| 2026-02-02 | BENNETT C FRANK EVP, Chief Scientific Officer | Option exercise 10b5-1 | +48,626 | $60.89 | $3.0M | 128,919 |
| 2026-02-02 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale 10b5-1 | −48,626 | $83.03 | $4.0M | 80,293 |
| 2026-02-02 | BENNETT C FRANK EVP, Chief Scientific Officer | Option exercise 10b5-1 | +16,463 | $32.60 | $537K | 96,756 |
| 2026-02-02 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale 10b5-1 | −16,463 | $83.03 | $1.4M | 80,293 |
| 2026-02-02 | BENNETT C FRANK EVP, Chief Scientific Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −16,463 | 2,406 |
Page 1 of 3 · 42 trades